Condition: Neuromyelitis Optica Spectrum Disorders (NMOSD) · Neuropathic Pain · Sponsor: Tang-Du Hospital
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study is a multicenter, prospective, randomized, double-blind, placebo-controlled exploratory investigation conducted in China.
This description comes directly from the study's public registry record.
Jun Guo, MD · 86-29-8477 8844 · guojun_81@163.com
Always discuss trial participation with your own doctor first.
| Beijing Tiantan Hospital, Capital Medical University | Beijing, Beijing Municipality, China | — |
| the First Hospital of Tsinghua University | Beijing, Chaoyang, China | — |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | — |
| The First Affiliated Hospital of Harbin Medical University | Harbin, Heilongjiang, China | — |
| Inner Mongolia People's Hospital | Hohhot, Inner Mongolia, China | — |
| The First Hospital of Jilin University | Changchun, Jinlin, China | — |
| The First Hospital of China Medical University | Shenyang, Liaoning, China | — |
| Tangdu Hospotal | Xi'an, Shaanxi, China | — |
| Xinjiang Uygur Autonomous Region People's Hospital | Ürümqi, Xinjiang Uygur Autonomous Region, China | — |
| The First Affiliated Hospital of Kunming Medical University | Kunming, Yunnan, China | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.